Applied Behavior Analysis for the Treatment of Down Syndrome
Customize your policy alerts
Sign up for lucet Policy 20.5.006 alerts
Get alerted when Policy 20.5.006 changes without checking for updates manually.
Monitor payer policy activity
Governs medical necessity and authorization requirements for Applied Behavior Analysis (ABA) services for Lucet members diagnosed with Down syndrome (without comorbid ASD) and applies to providers and Lucet workforce managing ABA benefits for plan year 2024.
No material clinical or coverage changes in this revision.
Coverage Criteria for ABA Services (Down syndrome)
ABA Pre-treatment Assessment
Covered when ALL of the following are met for pre-treatment assessment
Initial ABA Treatment Authorization
Covered when ALL of the following are met for initial ABA treatment authorization
Continued ABA Treatment Authorization
Covered when ALL of the following are met for continued ABA treatment
Comorbid diagnoses of Down syndrome and Autism Spectrum Disorder (ASD) are managed under a separate policy: 20.5.005 Applied Behavior Analysis for the Treatment of Autism Spectrum Disorder. This policy (20.5.006) applies to ABA coverage decisions for members with Down syndrome without comorbid ASD. Additionally, ABA is not intended to achieve academic performance and other non‑ABA treatments or educational interventions fall outside the scope of this policy.
Requests for ABA services that do not include the required diagnostic confirmation, baseline assessments, or treatment focus will not meet medical necessity. Specifically, documentation must satisfy initial authorization items including: a confirmed diagnosis per the pre‑treatment assessment, a psychological assessment with adaptive behavior testing and cognitive evaluation (with formal reports), baseline data completed prior to or scheduled within 90 days and not older than specified timeframes (e.g., adaptive behavior assessment within 6 months of treatment start), and treatment goals focused on active symptoms and substantial deficits requiring the expertise of a Behavior Analyst. Services that are substitutes for psychotherapy, occupational therapy, or other medical/behavioral services are also not appropriate under this policy.
Provider Requirements and Authorization Actions
Prior Authorization Required
Prior authorization is required for pre-treatment assessment, initial ABA, and continued ABA. Requests must demonstrate a confirmed diagnosis (including genetic confirmation for Down Syndrome when specified), medically necessary hours not exceeding documented need, and alignment with the documentation and assessment requirements described below.
- Applies to pre-treatment assessment, initial treatment, and continued treatment requests
- Hours requested must be supported by documented need and not exceed what is required to complete the service
- Diagnosis must be documented and, for Down Syndrome without comorbid ASD, confirmed by genetic testing
Provider Actions — Coordinate Treatment with Other Services
Treatment must be coordinated with other services and is not a substitute for psychotherapy, occupational therapy, or other medical or behavioral health services. Providers must document ongoing coordination of care, safety planning, and discharge planning, and ensure that ABA is delivered in the appropriate setting and intensity for the member's clinical needs.
- ABA is not a substitute for psychotherapy, OT, or other medical/behavioral services
- Detailed, individualized coordination of care, safety planning, and discharge planning are required and must be documented
- Treatment setting and intensity must be appropriate to where target behaviors occur and where treatment will impact those behaviors
Provider Actions — Documentation and Baseline Assessment Required
Requests must include comprehensive psychological assessment documentation: adaptive behavior testing, cognitive evaluation, formal reports with scores, and baseline data. Baseline data must be completed prior to or scheduled within 90 days of the assessment and no older than five years (with some assessments required within shorter windows as noted).
- Psychological assessment including adaptive behavior testing and cognitive evaluation with formal reports and score details
- Baseline data completed prior to or scheduled within 90 days of the assessment and not older than 5 years
- Required baseline elements include developmental/cognitive evaluation, adaptive behavior assessment within 6 months of treatment start, neurological evaluation as part of a comprehensive physical, and any information required by state law
Provider Actions — Denial Risks
Requests may be denied if the member lacks a documented diagnosis (including required genetic confirmation for Down Syndrome without comorbid ASD) or if the hours requested exceed the documented clinical need.
- Denial risk when diagnosis is not documented or genetic confirmation is absent where required
- Denial risk when requested hours exceed what is supported by assessments, baseline data, and treatment plan
Key Definitions
Background
Down syndrome (also called Trisomy 21) is a chromosomal condition in which an individual has an extra copy of chromosome 21. This additional genetic material alters development of the body and brain and commonly causes developmental and cognitive delays, including delayed language development and general reductions in intellectual functioning (often in the mildly‑to‑moderately low range). Clinical presentation and physical features vary substantially between individuals; ABA services under this policy are intended to address behavioral and functional deficits associated with Down syndrome rather than provide non‑behavioral or educational interventions.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.